Skip to content

Drug interactions

Aprepitant + Irinotecan

Severity: Minor

Aprepitant and Irinotecan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Irinotecan and its active metabolite SN-38 are affected by CYP3A4, and inhibition could alter exposure. Studies with fosaprepitant did not show a clinically meaningful change in irinotecan pharmacokinetics, though monitoring remains sensible.

What this interaction means in plain words

Aprepitant and Irinotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Aprepitant belongs to Gastrointestinal Tract; Irinotecan belongs to Oncology.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4, which may alter irinotecan oxidative metabolism, but the net effect appears small.

What to do

Monitor for diarrhea and neutropenia as routine, and no dose adjustment is usually needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Irinotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Irinotecan?

MediHelp rates the interaction as minor. Aprepitant and Irinotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Irinotecan and its active metabolite SN-38 are affected by CYP3A4, and inhibition could alter exposure. Studies with fosaprepitant did not show a clinically meaningful change in irinotecan pharmacokinetics, though monitoring remains sensible.

How serious is the interaction between Aprepitant and Irinotecan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for diarrhea and neutropenia as routine, and no dose adjustment is usually needed.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in